Highlights and Quick Summary
- Annual Average Days of Receivables for 2021 was 68.31 (a -61.45% decrease from previous year)
- Annual Average Days of Receivables for 2020 was 177.17 (a 7.04% increase from previous year)
- Annual Average Days of Receivables for 2019 was 165.52 (a 118.17% increase from previous year)
- Twelve month Average Days of Receivables ending September 30, 2022 was 65.23 (a -12.31% decrease compared to previous quarter)
- Twelve month trailing Average Days of Receivables decreased by -4.51% year-over-year
Trailing Average Days of Receivables for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 65.23 | 74.38 | 70.69 | 68.31 |
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Days of Receivables of BioCryst Pharmaceuticals, Inc.
Most recent Average Days of Receivablesof BCRX including historical data for past 10 years.Interactive Chart of Average Days of Receivables of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Average Days of Receivables for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 68.31 |
| 2020 | – | – | – | – | 177.17 |
| 2019 | – | – | – | – | 165.52 |
| 2018 | – | – | – | – | 75.87 |
| 2017 | – | – | – | – | 88.65 |
| 2016 | – | – | – | – | 121.44 |
| 2015 | – | – | – | – | 47.22 |
| 2014 | – | – | – | – | 254.55 |
| 2013 | – | – | – | – | 44.54 |
| 2012 | – | – | – | – | 63.33 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology